Tumour necrosis factor-blocking agents in persistent oligoarticular juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children Register

Anink, J.; Otten, M.H.; Prince, F.H.M.; Hoppenreijs, E.P.A.H.; Wulffraat, N.M.; Swart, J.F.; ... ; Suijlekom-Smit, L.W.A. van (2013)

Article / Letter to editor

• oligoarticular juvenile idiopathic arthritis
• etanercept
• adalimumab
• response
• anti-tumour necrosis factor
• biologic therapy

• All authors: Anink, J.; Otten, M.H.; Prince, F.H.M.; Hoppenreijs, E.P.A.H.; Wulffraat, N.M.; Swart, J.F.; Cate, R. ten; Rossum, M.A.J. van; Berg, J.M. van den; Dolman, K.M.; Koopman-Keemink, Y.; Armbrust, W.; Kamphuis, S.; Pelt, P.A. van; Gorter, S.L.; Suijlekom-Smit, L.W.A. van
• Date: 2013-04-30
• Journal: Rheumatology
• Volume: 52
• Issue: 4
• Pages: 712 - 717
• DOI: doi:10.1093/rheumatology/kes373